Evidence map›Paper›PMID 40736568›Full record

ReviewJournal of neural transmission (Vienna, Austria : 1996)2025

Far from being the end of the road: taking a closer look at neuropalliative care in Parkinson's disease.

Manon Auffret, Fran Borovecki, Beatrice Heim, Wolfgang H Jost, Per Odin, Fabrizio Stocchi, Maja Trost, Marc Vérin

Abstract readReview
In one paragraph

Review in Journal of neural transmission (Vienna, Austria : 1996), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Frailty in Parkinson's disease: time to integrate it into treatment decision-making?Journal of neural transmission (Vienna, Austria : 1996) · 2026
    Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Manon AuffretFrance Développement Electronique (FDE), Monswiller, France. auffret.manon@gmail.com.ORCID 0000-0002-7003-4084
Fran BoroveckiDepartment for Personalized Medicine, University Hospital Center Zagreb, Zagreb, Croatia.
Beatrice HeimDepartment of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
Wolfgang H JostParkinson-Klinik Ortenau, Homburg, Germany.
Per OdinDivision of Neurology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
Fabrizio StocchiUniversity San Raffaele Rome and Institute for Research and Medical Care San Raffaele, Rome, Italy.
Maja TrostDepartment of Neurology, University Medical Centre Ljubljana, Ljubljana, 1000, Zaloška cesta 2, Slovenia.
Marc VérinBrain-Clinicial and Experimental Neuroplasticity (B-CLINE), Laboratoire Interdisciplinaire pour l'Innovation et la Recherche en Santé d'Orléans (LI2RSO), Université d'Orléans, Orléans, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Parkinson's disease (PD) is now recognized as a multisystem, heterogeneous neurodegenerative disease with fluctuating trajectories and complex symptom profiles. Despite therapeutic advances, many patients (particularly women and those in late stages) and their caregivers face substantial unmet needs across physical, psychological, social, and spiritual domains, which highlight the need for a more integrative care model. Palliative care, defined as holistic, person-centered care for individuals with life-limiting illnesses, is increasingly recognized as particularly relevant in PD, from early to terminal stages. However, its implementation in neurology remains limited, notably due to persistent misconceptions, and delayed or absent referrals. This narrative review therefore aims to equip PD care teams with a clearer understanding of palliative care principles and their applicability to PD, by synthesizing emerging evidence in neuropalliative care, and providing practical recommendations for integration into routine neurological practice. Building on the specificities of quality of care for chronic conditions, optimal neuropalliative care in PD involves regular (re)assessment of symptoms and priorities, effective management of the chronic-palliative interface, good communication, continuity of care (including neurological care until the end of life), and a multidisciplinary network of professionals working both in the community and in specialized clinics, while leaving room for the involvement of caregivers. Far from being "the end of the road", neuropalliative care is a strategic and compassionate response to the evolving complexity of PD, which ultimately enhances quality of life, supports families, and reinforces the neurologist's pivotal role in longitudinal, person-centered care.

Indexed as

Palliative CareParkinson DiseaseHumansDisease trajectoriesEnd-of-lifeNeuropalliative carePalliative careParkinson’s diseaseUncertainty

Identifiers

PMID40736568
PMCPMC12630181

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.